ASEP.CNCNQHealthcare · Biotechnology

Asep Medical Holdings Inc

$0.13-58.06%($-0.18)

TickerSpark Score

32/100

Poor

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ASEP.CN research report →

52-Week Range10% of range

Low $0.09

Current $0.13

High $0.50

Companyasepmedical.com

Asep Medical Holdings Inc. , through its subsidiary, ASEP Medical Inc. focuses on developing an early diagnostic tool for Sepsis and peptide therapeutic treatments for multiple applications.

CEO: Richard Heinzl
IPO: 2021
Employees: 6
HQ: Vancouver, BC, CA

Price Chart

-74.00% · this period

Valuation

Market Cap: $1.45M
P/E: -0.98
P/S: 68.41
P/B: 0.64
EV/EBITDA: -0.17
Div Yield: 0.00%

Profitability

Gross Margin: -538.03%
Op Margin: -36524.42%
Net Margin: -38918.30%
ROE: -58.60%
ROIC: -31.34%

Growth & Income

Revenue: $21.14K · 0.00%
Net Income: $-8,227,328 · -42.90%
EPS: $-0.13 · -30.00%
Op Income: $-7,721,263
FCF YoY: 24.84%

Performance & Tape

52W High: $0.50
52W Low: $0.09
50D MA: $0.30
200D MA: $0.39
Beta: -1.74
Avg Volume: 3.20K

Get TickerSpark's AI analysis on ASEP.CN

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime